Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 592

1.

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children.

Olotu A, Fegan G, Wambua J, Nyangweso G, Leach A, Lievens M, Kaslow DC, Njuguna P, Marsh K, Bejon P.

N Engl J Med. 2016 Jun 30;374(26):2519-29. doi: 10.1056/NEJMoa1515257.

PMID:
27355532
2.

Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study.

Mogeni P, Williams TN, Fegan G, Nyundo C, Bauni E, Mwai K, Omedo I, Njuguna P, Newton CR, Osier F, Berkley JA, Hammitt LL, Lowe B, Mwambingu G, Awuondo K, Mturi N, Peshu N, Snow RW, Noor A, Marsh K, Bejon P.

PLoS Med. 2016 Jun 28;13(6):e1002047. doi: 10.1371/journal.pmed.1002047. eCollection 2016 Jun.

3.

Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.

Lawson R, King F, Marsh K, Altincatal A, Cimen A.

Adv Ther. 2016 Jun 24. [Epub ahead of print]

PMID:
27342744
4.

Assessing Supersaturation and Its Impact on In Vivo Bioavailability of a Low-Solubility Compound ABT-072 With a Dual pH, Two-Phase Dissolution Method.

Shi Y, Erickson B, Jayasankar A, Lu L, Marsh K, Menon R, Gao P.

J Pharm Sci. 2016 Jun 16. pii: S0022-3549(16)41438-3. doi: 10.1016/j.xphs.2016.04.036. [Epub ahead of print]

PMID:
27321234
5.

Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.

Vidadala RS, Rivas KL, Ojo KK, Hulverson MA, Zambriski JA, Bruzual I, Schultz TL, Huang W, Zhang Z, Scheele S, DeRocher AE, Choi R, Barrett LK, Siddaramaiah LK, Hol WG, Fan E, Merritt EA, Parsons M, Freiberg G, Marsh K, Kempf DJ, Carruthers VB, Isoherranen N, Doggett JS, Van Voorhis WC, Maly DJ.

J Med Chem. 2016 Jul 14;59(13):6531-46. doi: 10.1021/acs.jmedchem.6b00760. Epub 2016 Jul 1.

PMID:
27309760
6.

International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework.

Malone DC, Berg NS, Claxton K, Garrison LP Jr, IJzerman M, Marsh K, Neumann PJ, Sculpher M, Towse A, Uyl-de Groot C, Weinstein MC.

J Clin Oncol. 2016 Jun 13. pii: JCO644328. [Epub ahead of print] No abstract available.

PMID:
27298420
7.

Mind the gap: jumping from vaccine licensure to routine use.

O'Brien KL, Binka F, Marsh K, Abramson JS.

Lancet. 2016 May 7;387(10031):1887-9. doi: 10.1016/S0140-6736(16)30394-4. No abstract available.

PMID:
27203633
8.

A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.

Chan JA, Howell KB, Langer C, Maier AG, Hasang W, Rogerson SJ, Petter M, Chesson J, Stanisic DI, Duffy MF, Cooke BM, Siba PM, Mueller I, Bull PC, Marsh K, Fowkes FJ, Beeson JG.

Cell Mol Life Sci. 2016 May 19. [Epub ahead of print]

PMID:
27193441
9.

Metabolism and Disposition of the Hepatitis C Protease Inhibitor Paritaprevir in Humans.

Shen J, Serby M, Reed A, Lee AJ, Zhang X, Marsh K, Khatri A, Menon R, Kavetskaia O, Fischer V.

Drug Metab Dispos. 2016 Aug;44(8):1164-73. doi: 10.1124/dmd.115.067488. Epub 2016 May 13.

PMID:
27179127
10.

Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in Humans.

Shen J, Serby M, Reed A, Lee AJ, Menon R, Zhang X, Marsh K, Wan X, Kavetskaia O, Fischer V.

Drug Metab Dispos. 2016 Aug;44(8):1139-47. doi: 10.1124/dmd.115.067512. Epub 2016 May 13.

PMID:
27179126
11.

Africa in transition: the case of malaria.

Marsh K.

Int Health. 2016 May;8(3):155-6. doi: 10.1093/inthealth/ihw022. No abstract available.

PMID:
27178672
12.

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.

Ochola-Oyier LI, Okombo J, Wagatua N, Ochieng J, Tetteh KK, Fegan G, Bejon P, Marsh K.

Malar J. 2016 May 6;15(1):261. doi: 10.1186/s12936-016-1304-8.

13.

Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast.

Kangoye DT, Noor A, Midega J, Mwongeli J, Mkabili D, Mogeni P, Kerubo C, Akoo P, Mwangangi J, Drakeley C, Marsh K, Bejon P, Njuguna P.

Malar J. 2016 Apr 14;15(1):213. doi: 10.1186/s12936-016-1260-3.

14.

Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.

Browne C, Muszbek N, Chapman R, Marsh K, Gould IM, Seaton RA, Allen M.

Int J Antimicrob Agents. 2016 May;47(5):357-61. doi: 10.1016/j.ijantimicag.2016.02.006. Epub 2016 Mar 19.

PMID:
27061774
15.

Expanding Health Technology Assessments to Include Effects on the Environment.

Marsh K, Ganz ML, Hsu J, Strandberg-Larsen M, Gonzalez RP, Lund N.

Value Health. 2016 Mar;19(2):249-54. doi: 10.1016/j.jval.2015.11.008. Epub 2016 Jan 21.

PMID:
27021760
16.

Multiple Criteria Decision Analysis for Health Care Decision Making-Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.

Marsh K, IJzerman M, Thokala P, Baltussen R, Boysen M, Kaló Z, Lönngren T, Mussen F, Peacock S, Watkins J, Devlin N.

Value Health. 2016 Mar;19(2):125-37. doi: 10.1016/j.jval.2015.12.016. Epub 2016 Mar 7.

PMID:
27021745
17.

Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria.

Warimwe GM, Abdi AI, Muthui M, Fegan G, Musyoki JN, Marsh K, Bull PC.

Infect Immun. 2016 Apr 22;84(5):1331-5. doi: 10.1128/IAI.00772-15. Print 2016 May.

18.

Depressive symptoms in midlife: the role of reproductive stage.

Almeida OP, Marsh K, Flicker L, Hickey M, Sim M, Ford A.

Menopause. 2016 Jun;23(6):669-75. doi: 10.1097/GME.0000000000000598.

PMID:
26859342
19.

Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.

Thokala P, Devlin N, Marsh K, Baltussen R, Boysen M, Kalo Z, Longrenn T, Mussen F, Peacock S, Watkins J, Ijzerman M.

Value Health. 2016 Jan;19(1):1-13. doi: 10.1016/j.jval.2015.12.003. Epub 2016 Jan 8.

PMID:
26797229
20.

Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.

Murungi LM, Sondén K, Llewellyn D, Rono J, Guleid F, Williams AR, Ogada E, Thairu A, Färnert A, Marsh K, Draper SJ, Osier FH.

Infect Immun. 2016 Mar 24;84(4):950-63. doi: 10.1128/IAI.01120-15. Print 2016 Apr.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk